A pilot study of the effects of a perflubron emulsion, AF 0104, on mixed venous oxygen tension in anesthetized surgical patients

被引:65
作者
Wahr, JA
Trouwborst, A
Spence, RK
Henny, CP
Cernaianu, AC
Graziano, GP
Tremper, KK
Flaim, KE
Keipert, PE
Faithfull, NS
Clymer, JJ
机构
[1] UNIV MICHIGAN,DEPT ANESTHESIOL,ANN ARBOR,MI 48109
[2] UNIV AMSTERDAM,MED CTR,AMSTERDAM,NETHERLANDS
[3] UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT SURG,CAMDEN,NJ 08103
[4] ALLIANCE PHARMACEUT CORP,SAN DIEGO,CA 92121
关键词
D O I
10.1097/00000539-199601000-00018
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
A pilot study of a perfluorochemical (PFC) emulsion was undertaken to determine whether administration of a perflubron emulsion could result in measurable changes in mixed venous oxygen tension. Seven adult surgical patients received a 0.9-g PFC/kg intravenous dose of perflubron emulsion after acute normovolemic hemodilution (ANH). Hemodynamic and oxygen transport data were collected before and after ANH, immediately after PFC infusion, and at approximate 15-min intervals throughout the surgical period. There were no clinically significant hemodynamic changes associated with the administration of the PFC emulsion. There was a significant increase in mixed venous oxygen tension (Pvo(2)) after the PFC infusion, while cardiac output and oxygen consumption were unchanged. As surgery progressed, the hemoglobin concentration decreased with ongoing blood loss while Pvo, values remained at or above predosing levels. Peak perflubron blood levels were 0.8 g/dL immediately postinfusion, and approximately 0.3 g/dL at 1 h. This pilot study demonstrates that administration of perflubron emulsion results in measurable changes in mixed venous oxygen tension during intraoperative ANH.
引用
收藏
页码:103 / 107
页数:5
相关论文
共 9 条
[1]  
Biro G. P., 1993, Transfusion Medicine Reviews, V7, P84, DOI 10.1016/S0887-7963(93)70127-3
[2]  
CLARK LC, 1966, SCIENCE, V152, P155
[3]  
GEYER RP, 1968, FED PROC, V27, P384
[4]   FLUOSOL-DA AS A RED-CELL SUBSTITUTE IN ACUTE ANEMIA [J].
GOULD, SA ;
ROSEN, AL ;
SEHGAL, LR ;
SEHGAL, HL ;
LANGDALE, LA ;
KRAUSE, LM ;
RICE, CL ;
CHAMBERLIN, WH ;
MOSS, GS .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (26) :1653-1656
[5]  
KEIPERT PE, 1994, ADV EXP MED BIOL, V345, P197
[6]   TRANSFUSION - MORBIDITY AND MORTALITY [J].
NICHOLLS, MD .
ANAESTHESIA AND INTENSIVE CARE, 1993, 21 (01) :15-19
[7]   THE PREOPERATIVE TREATMENT OF SEVERELY ANEMIC PATIENTS WITH A PERFLUOROCHEMICAL OXYGEN-TRANSPORT FLUID, FLUOSOL-DA [J].
TREMPER, KK ;
FRIEDMAN, AE ;
LEVINE, EM ;
LAPIN, R ;
CAMARILLO, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (05) :277-283
[8]   HEMODYNAMIC PROFILE OF ADVERSE CLINICAL REACTIONS TO FLUOSOL-DA 20-PERCENT [J].
TREMPER, KK ;
VERCELLOTTI, GM ;
HAMMERSCHMIDT, DE .
CRITICAL CARE MEDICINE, 1984, 12 (05) :428-431
[9]   ACTIVATION OF PLASMA COMPLEMENT BY PERFLUOROCARBON ARTIFICIAL BLOOD - PROBABLE MECHANISM OF ADVERSE PULMONARY REACTIONS IN TREATED PATIENTS AND RATIONALE FOR CORTICOSTEROID PROPHYLAXIS [J].
VERCELLOTTI, GM ;
HAMMERSCHMIDT, DE ;
CRADDOCK, PR ;
JACOB, HS .
BLOOD, 1982, 59 (06) :1299-1304